Assistant Professor of Surgery
Office:
915 S. Lasalle Street, 204 Sorf (Bldg. 41) Box 2926, Durham, NC 27710
I am an immunologist, with a focus to characterize the immune system in response to infectious and non-infectious diseases including cancer, HIV, autoimmune disease, and transplantation. My goals are to identify novel biomarkers/immune signatures that clinicians can utilize to diagnosis, predict disease outcomes, and determine patients' response to treatment.
Education and Training
- Ph.D., University of Alabama Birmingham, 2010
Selected Grants
- In Vivo Knee Motion and ACL Biomechanics During Dynamic Activities
- RARE DISEASE NETWORK FOR MYASTHENIA GRAVIS
- Defining the clinical phenotype and immunopathology of seronegative MG
- VTEU Task D Option 2 Protocol FY.2015.A4D14.0033
- Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy
- Mechanisms of immune checkpoint resistance mediated by LKB1 tumor suppressor in lung cancer
- Metabolic Pathways Of Pathogenic Th17 Cells In Myasthenia Gravis
- Characterization of porcine synovial cells in co-culture
- Feasibility of using Bortezomib-based immunosuppressive approach to deplete anti-AAV antibodies in mice
- Overcoming checkpoint blockade resistance in ovarian cancer
- Pathogenic Th17 cell pathology in CIDP
- Immune modulation of CaMKK2 in the ovarian tumor microenvironment
- GAA-iTEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pome Disease Patients
- Immunologic Changes in the Treatment of Myasthenia Gravis
- Role of CD4 T cell subsets as drivers of MG disease
- The interface of B and T cells in Transplant
- Acetylcholine receptor binding B cells as biomarker for myasthenia gravis
- High Impact Pilot Project on Myasthenia Gravis and Related Neuromuscular Junction Disorders
- Profiling of ACHR-Specific B Cells in Myasthenia Gravis
- VTEU Task A Protocol FY.2015.A4D14.0033